Pharmacokinetics (PK) Is The Scientific Study Of The Absorption, Distribution, Metabolism, And Elimination Of Drugs From The Body. It Is A Multidisciplinary Field That Integrates Aspects Of Pharmacology, Toxicology, Biochemistry, And Physiology To Elucidate Drug-Body Interactions. PK Provides An Understanding Of How Drugs Are Metabolized By The Body And How They Interact With The Body Systems, Allowing For The Design Of Appropriate And Effective Regimens For Drug Administration. Knowledge Of PK Is Essential For The Proper Dosing Of Drugs, And Allows Clinicians To Choose A Suitable Treatment Based On A Patient's Individual Characteristics. PK Studies Are Conducted In Animals And Laboratory Settings To Evaluate And Quantify The Different Processes Involved In Drug Absorption, Distribution, Metabolism, And Elimination. The PK Parameters Obtained From These Studies Are Then Used To Calculate The Drug's Dosage, Or Dose Range, To Achieve The Desired Therapeutic Response. PK Studies Also Provide Information About The Potential For Drug Side Effects Or Drug-Drug Interactions. The PK Of A Drug Is Typically Characterized By Its Efficacy, The Amount Of Drug Reaching The Target Site, And Its Safety, The Ability Of The Drug To Be Eliminated From The Body Without Causing Harm. PK Also Allows For The Identification Of Potential Drug Targets And Their Associated Pathways, Which Contributes To A Better Understanding Of The Drug's Pharmacological Mechanism And The Potential For Improved Therapeutic Strategies. The Major PK Parameters Studied Include: Absorption, Distribution, Metabolism, Excretion, Metabolism Pathways, Drug Interactions, Pharmacokinetics-Pharmacodynamics (PK-PD) Relationship, And Bioavailability. These Parameters Are Used To Provide Information To Clinicians And Researchers Regarding The Pharmacokinetic And Pharmacodynamic Effects Of A Drug On The Body. PK Is A Valuable Tool For Clinicians And Researchers In Drug Development, Clinical Practice, And Medical Education. It Can Help Clinicians To Efficiently Design Regimens For Administering Drugs And Optimize Drug Therapy, While Researchers Gain Insight Into Drug Metabolism Pathways To Allow The Design Of New And Improved Drugs With Fewer Side Effects.
Title : Advances in plasma-based waste treatment for sustainable communities
Hossam A Gabbar, Ontario Tech University, Canada
Title : Nanostructured biodevices based on carbon nanotubes and glyconanoparticles for bioelectrocatalytic applications
Serge Cosnier, Silesian University of Technology, Poland
Title : Carbon capture and storage: The impact of impurities in CO2 streams
Andy Brown, Progressive Energy Ltd, United Kingdom
Title : Supramolecular nano chemistries: Fighting viruses, inhibiting bacteria and growing tissues
Thomas J Webster, Hebei University of Technology, China
Title : Chemical engineering of vanadium and tantalum zeolites for application in environmental catalysis
Stanislaw Dzwigaj, Sorbonne Universite, France
Title : Disrupting TNF-α and TNFR1 interaction: Computational insights into the potential of D-Pinitol as an anti-inflammatory therapeutic
Ferran Acuna Pares, Universidad Internacional de la Rioja (UNIR), Spain